Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.
Tak WY, Ryoo BY, Lim HY, Kim DY, Okusaka T, Ikeda M, Hidaka H, Yeon JE, Mizukoshi E, Morimoto M, Lee MA, Yasui K, Kawaguchi Y, Heo J, Morita S, Kim TY, Furuse J, Katayama K, Aramaki T, Hara R, Kimura T, Nakamura O, Kudo M. Tak WY, et al. Among authors: mizukoshi e. Invest New Drugs. 2018 Dec;36(6):1072-1084. doi: 10.1007/s10637-018-0658-x. Epub 2018 Sep 10. Invest New Drugs. 2018. PMID: 30198057 Clinical Trial.
Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma.
Yamashita T, Arai K, Sunagozaka H, Ueda T, Terashima T, Yamashita T, Mizukoshi E, Sakai A, Nakamoto Y, Honda M, Kaneko S. Yamashita T, et al. Among authors: mizukoshi e. Oncology. 2011;81(5-6):281-90. doi: 10.1159/000334439. Epub 2011 Nov 30. Oncology. 2011. PMID: 22133996 Clinical Trial.
[A case report of S-1 monotherapy for advanced hepatocellular carcinoma].
Yamashita T, Arai K, Terashima T, Sunagozaka H, Shimakami T, Yamashita T, Mizukoshi E, Sakai A, Honda M, Kaneko S. Yamashita T, et al. Among authors: mizukoshi e. Gan To Kagaku Ryoho. 2012 Sep;39(9):1435-7. Gan To Kagaku Ryoho. 2012. PMID: 22996786 Japanese.
Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.
Hayashi T, Yamashita T, Terashima T, Suda T, Okada H, Asahina Y, Hayashi T, Hara Y, Nio K, Sunagozaka H, Takatori H, Arai K, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Kaneko S. Hayashi T, et al. Among authors: mizukoshi e. BMC Cancer. 2017 Dec 19;17(1):870. doi: 10.1186/s12885-017-3889-x. BMC Cancer. 2017. PMID: 29258450 Free PMC article.
175 results